Zheng Jane Li

Crystal forms of azithromycin

CRYSTAL FORMS OF AN IMIDAZOLE DERIVATIVE

Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid

Complexes of E-2-Methoxy-N(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinzazolin-6-YL}-allyl)-acetamide, their method of production, and use

Amorphous und crystal forms of (5-chloro-2-{2-

Crystal forms of e-2-methoxy-n-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide

NEW CRYSTAL FORM OF AZITHROMYCIN

A PROCESS FOR THE PREPARATION OF ESSENTIALLY PURE, CRYSTALLINE, N-[({2-[4-(2-ETHYL-4,6-DIMETHYL-1H-IMIDAZO[4,5-C]PYRIDIN-1-YL)PHENYL]ETHYL}AMINO)CARBONYL]-4-METHYLBENZENESULFONAMIDE POLYMORPH FORM A

Crystalline form of azithromycin

Crystal form of imidazole derivative